Food and Drug Law Weekly

Alpharma Inc. - Alpharma Adopts Limited Duration Shareholder Rights Plan

Alzheimer Disease - Anavex completes successful preclinical studies on lead Alzheimers drug candidate

American Academy of Ophthalmology - Use of Electronic Health Records by Eye M.D.s; Two Studies Refine Risks and Predictors for Advanced Macular Degeneration

BioMed Central - Health of Afghan children jeopardized by family behaviors, not just war

Biopharmaceuticals - Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems

Drug Development - Evotec and Boehringer Ingelheim Achieve Milestone in Joint Discovery Collaboration

Duke University Medical Center - Post-marketing studies finding adverse events in drugs used in children

Pennsylvania Department of Environmental Protection - State's Largest Waste Tire Pile No More

Addiction Medicine - New addiction medicine research from Brandeis University discussed

Adolor Corporation - Adolor Regains Rights to Entereg alvimopan for OBD

Alpharma Inc. - Alpharma Announces Acceptance of the EMBEDA Capsule NDA Filing

American Chemistry Council - ACC Applauds California's Decision to Not Ban Food-Contact Products Containing Bisphenol A

Anadis Limited - Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS

Anadis Ltd. - Clinical Trial Protocol Against Cancer Therapy Side Effects Mucositis Approved

Anthrax Vaccines - Reports summarize anthrax vaccines research from Medical Research Institute

Behavior - Recent findings from Carnegie Mellon University highlight research in behavior

BioForm Medical, Inc. - 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment

Bioscience - ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems

Biovail Corporation - Biovail Announces Filing of ANDA for Fenofibrate Tablets

Breast Cancer - Agendia Launches TargetPrint(R) for Breast Cancer Patients

Breast Cancer - PhRMA Members Lead the World in Cancer Research Investment

Bridge Laboratories - Bridge Laboratories' China Study Data Accepted by the FDA

Cardiometabolic Disease - CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases

Cataracts - September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging

Celator Pharmaceuticals - Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351

Celgene Corporation - Amrubicin Receives FDA Fast Track Designation for the Treatment of Small Cell Lung Cancer after First-Line Chemotherapy

Chemical Warfare - Research findings from University of Cincinnati, Department of Chemistry update understanding of chemical warfare

China Biologic Products, Inc. - China Biologic's Production Facility Renews GMP Certification

Concentric Pharma Advertising - Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)

Cordis Corporation - Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease

Cordis Corporation - First Patient Enrolled in Study Evaluating S.M.A.R.T. Nitinol Self-Expandable Stent System in Leg Disease

Covidien - Covidien Launches Evident Microwave Ablation System Offering Surgical Oncologists and Interventional Radiologists Fast, Efficient Tool to Ablate Soft Tissue

Cystic Fibrosis - Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins

Dengue Fever - Reports from Chang Gung Memorial Hospital describe recent advances in dengue fever

Drug Development - Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics

Drug Resistance - New findings from University of London in the area of drug resistance described

Drug Safety - New Hamner-UNC Center for Drug Safety Sciences

Emergent BioSolutions Inc. - Emergent BioSolutions Receives $24 Million Development Contract from the Department of Health and Human Services to Fund Continued Development of Anthrax Monoclonal Antibody

Enzyme Research - Research data from F. Dorandeu and colleagues update understanding of enzyme research

Escherichia Coli - Reports outline Escherichia coli research from Department of Agriculture

EthicAd - Prescription Drug Advertising Subject of New FDA Web Site for Consumers

European Vaccination Group EVG Uk Ltd - Benefits of Seasonal Flu Vaccination in the Workplace

Exosome Diagnostics, Inc. - Exosome Diagnostics Announces Additions to Management Team

Explorer's Bounty - Explorer's Bounty Brewing Up a Tempest in a Teapot with New Line of Organic Teas

Expression Genetics, Inc. - Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover

Fairway Medical Technologies, Inc. - Fairway Medical Technology to Develop Biosensor for Blood Pathogens and Warfare Threats

Fibrin Tissue Adhesives - Study data from B. Horowitz and colleagues update understanding of fibrin tissue adhesives

GTC Biotherapeutics - FDA Assigns Priority Review to GTC Biotherapeutics' ATryn